Mind Medicine (MindMed), Inc. (MNMD)
MNMD has a market cap or net worth of $369.34 million. The enterprise value is $248.87 million.
The latest earnings date was Monday, May 16, 2022, before market open.
|Last Earnings Date||May 16, 2022|
MNMD has 422.44 million shares outstanding. The number of shares has increased by 8.38% in one year.
|Shares Change (YoY)||+8.38%|
|Shares Change (QoQ)||-0.03%|
|Owned by Insiders (%)||12.49%|
|Owned by Institutions (%)||12.92%|
|EV / Earnings||n/a|
|EV / Sales||n/a|
|EV / EBITDA||n/a|
|EV / EBIT||n/a|
|EV / FCF||n/a|
|Debt / Equity||0.00|
|Debt / EBITDA||0.00|
|Debt / FCF||0.00|
Return on equity (ROE) is -61.30%, which is considered low.
|Return on Equity (ROE)||-61.30%|
|Return on Assets (ROA)||-56.40%|
|Return on Capital (ROIC)||n/a|
|Revenue Per Employee||n/a|
|Profits Per Employee||-$2.36M|
|Effective Tax Rate||n/a|
Stock Price Statistics
The stock price has decreased by -71.86% in the last 52 weeks. The beta is 1.77, so MNMD's price volatility has been higher than the market average.
|52-Week Price Change||-71.86%|
|50-Day Moving Average||0.84|
|200-Day Moving Average||1.28|
|Average Volume (30 Days)||2,530,647|
Short Selling Information
The latest short interest is 38.14 million, so 9.03% of the outstanding shares have been sold short.
|Short % of Shares Out||9.03%|
|Short % of Float||10.26%|
|Short Ratio (days to cover)||13.77|
|Earnings Per Share (EPS)||-$0.23|
The company has $120.47 million in cash and no debt, giving a net cash position of $120.47 million or $0.29 per share.
|Cash & Cash Equivalents||120.47M|
|Net Cash Per Share||$0.29|
|Book Value Per Share||0.32|
In the last 12 months, operating cash flow was -$49.07 million and capital expenditures -$45,000, giving a free cash flow of -$49.12 million.
|Operating Cash Flow||-49.07M|
|Free Cash Flow||-49.12M|
|FCF Per Share||n/a|
Dividends & Yields
MNMD does not appear to pay any dividends at this time.
|Dividend Per Share||n/a|
|Dividend Growth (YoY)||n/a|
The average price target for MNMD is $5.48, which is 526.79% higher than the current price. The consensus rating is "Buy".
|Price Target Difference||526.79%|
The last stock split was on February 28, 2020. It was a reverse split with a ratio of 1:8.
|Last Split Date||Feb 28, 2020|